Gaas, Erwin N.

HRN: 16-07-93  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/29/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
07/29/2025
08/05/2025
IV
1.5g
Q6
Infected Wound Gluteal
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: